It all began with the toil of one enterprising individual, Shri. U N Mehta, when he ventured on his own to create history in the Indian pharmaceutical industry by successfully implementing the concept of niche marketing. His journey, characterized by ups and downs, reached a milestone in 1970 with the launch of Trinicalm Plus, an effective tranquilizer of the Central Nervous System (CNS), which is a niche segment.The foundations for Torrent were laid when 'Trinity Laboratories' began operations under the able guidance of Shri Mehta whose efforts are worthy of emulation.'Trinity' was renamed 'Torrent' and with the change not only did the company get a new name, but it also focused on establishing its own manufacturing facilities in the early 80s. Torrent augmented its efforts with the expansion of its manufacturing capacity, emphasis on marketing, and the creation of business opportunities through a focus on exports. Such a move translated to success and has made Torrent one of the world’s leading players in pharmaceuticals.Torrent’s strategies have evolved from building a strong domestic brand to diversified expansion and now, establishing a global brand. The company that had a humble beginning has now become one of the leading players in the pharmaceutical industry.In 2004, Torrent Pharma Philippines Inc. (TPPI) was established in the Philippines and it started its commercial operations in the year 2005. TPPI has made consistent and steady progress with its special interest in the CNS and CVMG therapeutic segments to become an important player in the Ethical, Branded Generic segment of the Philippine Pharmaceuticals market.
It all began with the toil of one enterprising individual, Shri. U N Mehta, when he ventured on his own to create history in the Indian pharmaceutical industry by successfully implementing the concept of niche marketing. His journey, characterized by ups and downs, reached a milestone in 1970 with the launch of Trinicalm Plus, an effective tranquilizer of the Central Nervous System (CNS), which is a niche segment.The foundations for Torrent were laid when 'Trinity Laboratories' began operations under the able guidance of Shri Mehta whose efforts are worthy of emulation.'Trinity' was renamed 'Torrent' and with the change not only did the company get a new name, but it also focused on establishing its own manufacturing facilities in the early 80s. Torrent augmented its efforts with the expansion of its manufacturing capacity, emphasis on marketing, and the creation of business opportunities through a focus on exports. Such a move translated to success and has made Torrent one of the world’s leading players in pharmaceuticals.Torrent’s strategies have evolved from building a strong domestic brand to diversified expansion and now, establishing a global brand. The company that had a humble beginning has now become one of the leading players in the pharmaceutical industry.In 2004, Torrent Pharma Philippines Inc. (TPPI) was established in the Philippines and it started its commercial operations in the year 2005. TPPI has made consistent and steady progress with its special interest in the CNS and CVMG therapeutic segments to become an important player in the Ethical, Branded Generic segment of the Philippine Pharmaceuticals market.
It all began with the toil of one enterprising individual, Shri. U N Mehta, when he ventured on his own to create history in the Indian pharmaceutical industry by successfully implementing the concept of niche marketing. His journey, characterized by ups and downs, reached a milestone in 1970 with the launch of Trinicalm Plus, an effective tranquilizer of the Central Nervous System (CNS), which is a niche segment.The foundations for Torrent were laid when 'Trinity Laboratories' began operations under the able guidance of Shri Mehta whose efforts are worthy of emulation.'Trinity' was renamed 'Torrent' and with the change not only did the company get a new name, but it also focused on establishing its own manufacturing facilities in the early 80s. Torrent augmented its efforts with the expansion of its manufacturing capacity, emphasis on marketing, and the creation of business opportunities through a focus on exports. Such a move translated to success and has made Torrent one of the world’s leading players in pharmaceuticals.Torrent’s strategies have evolved from building a strong domestic brand to diversified expansion and now, establishing a global brand. The company that had a humble beginning has now become one of the leading players in the pharmaceutical industry.In 2004, Torrent Pharma Philippines Inc. (TPPI) was established in the Philippines and it started its commercial operations in the year 2005. TPPI has made consistent and steady progress with its special interest in the CNS and CVMG therapeutic segments to become an important player in the Ethical, Branded Generic segment of the Philippine Pharmaceuticals market.